Human Genome Epidemiology Literature Finder
|
Records 1 - 10 (of 10 Records) |
| Query Trace: Ovarian Neoplasms and CYP2C8[original query] |
|---|
| Pharmacokinetics of paclitaxel in ovarian cancer patients and genetic polymorphisms of CYP2C8, CYP3A4, and MDR1. Journal of clinical pharmacology 2005 Jun 45 (6): 674-82. Nakajima Miki, Fujiki Yuto, Kyo Satoru, Kanaya Taro, Nakamura Mitsuhiro, Maida Yoshiko, Tanaka Masaaki, Inoue Masaki, Yokoi Tsuyos |
| Pharmacogenetic assessment of toxicity and outcome after platinum plus taxane chemotherapy in ovarian cancer: the Scottish Randomised Trial in Ovarian Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007 Oct 25 (29): 4528-35. Marsh Sharon, Paul Jim, King Cristi R, Gifford Gillian, McLeod Howard L, Brown Robe |
| Pharmacogenetic studies of Paclitaxel in the treatment of ovarian cancer. Basic & clinical pharmacology & toxicology 2009 Feb 104 (2): 130-7. Gréen Henrik, Söderkvist Peter, Rosenberg Per, Mirghani Rajaa A, Rymark Per, Lundqvist Elisabeth Avall, Peterson Cu |
| Impact of CYP2C8*3 on paclitaxel clearance: a population pharmacokinetic and pharmacogenomic study in 93 patients with ovarian cancer. The pharmacogenomics journal 2011 Apr 11 (2): 113-20. Bergmann T K, Brasch-Andersen C, Gréen H, Mirza M, Pedersen R S, Nielsen F, Skougaard K, Wihl J, Keldsen N, Damkier P, Friberg L E, Peterson C, Vach W, Karlsson M O, Brosen |
| Impact of CYP3A5*3 and CYP2C8-HapC on paclitaxel/carboplatin-induced myelosuppression in patients with ovarian cancer. Journal of pharmaceutical sciences 2011 Oct 100 (10): 4205-9. Gréen Henrik, Khan Muhammad Suleman, Jakobsen-Falk Ingrid, Åvall-Lundqvist Elisabeth, Peterson Cu |
| Polymorphisms in ABCB1 and ERCC2 associated with ovarian cancer outcome. International journal of molecular epidemiology and genetics 2011 2 (2): 185-95. Peethambaram Prema, Fridley Brooke L, Vierkant Robert A, Larson Melissa C, Kalli Kimberly R, Elliott Elaine A, Oberg Ann L, White Kristin L, Rider David N, Keeney Gary L, Cunningham Julie M, Hartmann Lynn C, Goode Ellen |
| Retrospective study of the impact of pharmacogenetic variants on paclitaxel toxicity and survival in patients with ovarian cancer. European journal of clinical pharmacology 2011 Jul 67 (7): 693-700. Bergmann Troels K, Gréen Henrik, Brasch-Andersen Charlotte, Mirza Mansoor R, Herrstedt Jørn, Hølund Berit, du Bois Andreas, Damkier Per, Vach Werner, Brosen Kim, Peterson Cu |
| Impact of ABCB1 variants on neutrophil depression: a pharmacogenomic study of paclitaxel in 92 women with ovarian cancer. Basic & clinical pharmacology & toxicology 2012 Feb 110 (2): 199-204. Bergmann Troels K, Brasch-Andersen Charlotte, Gréen Henrik, Mirza Mansoor R, Skougaard Kristin, Wihl Jessica, Keldsen Nina, Damkier Per, Peterson Curt, Vach Werner, Brøsen K |
| Analysis of over 10,000 Cases finds no association between previously reported candidate polymorphisms and ovarian cancer outcome. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2013 May 22 (5): 987-92. White Kristin L, Vierkant Robert A, Fogarty Zachary C, Charbonneau Bridget, Block Matthew S, Pharoah Paul D P, Chenevix-Trench Georgia, , Rossing Mary Anne, Cramer Daniel W, Pearce Celeste Leigh, Schildkraut Joellen M, Menon Usha, Kjaer Susanne Kruger, Levine Douglas A, Gronwald Jacek, Culver Hoda Anton, Whittemore Alice S, Karlan Beth Y, Lambrechts Diether, Wentzensen Nicolas, Kupryjanczyk Jolanta, Chang-Claude Jenny, Bandera Elisa V, Hogdall Estrid, Heitz Florian, Kaye Stanley B, Fasching Peter A, Campbell Ian, Goodman Marc T, Pejovic Tanja, Bean Yukie, Lurie Galina, Eccles Diana, Hein Alexander, Beckmann Matthias W, Ekici Arif B, Paul James, Brown Robert, Flanagan James M, Harter Philipp, du Bois Andreas, Schwaab Ira, Hogdall Claus K, Lundvall Lene, Olson Sara H, Orlow Irene, Paddock Lisa E, Rudolph Anja, Eilber Ursula, Dansonka-Mieszkowska Agnieszka, Rzepecka Iwona K, Ziolkowska-Seta Izabela, Brinton Louise, Yang Hannah, Garcia-Closas Montserrat, Despierre Evelyn, Lambrechts Sandrina, Vergote Ignace, Walsh Christine, Lester Jenny, Sieh Weiva, McGuire Valerie, Rothstein Joseph H, Ziogas Argyrios, Lubinski Jan, Cybulski Cezary, Menkiszak Janusz, Jensen Allan, Gayther Simon A, Ramus Susan J, Gentry-Maharaj Aleksandra, Berchuck Andrew, Wu Anna H, Pike Malcolm C, Van Denberg David, Terry Kathryn L, Vitonis Allison F, Doherty Jennifer A, Johnatty Sharon E, Defazio Anna, Song Honglin, Tyrer Jonathan, Sellers Thomas A, Phelan Catherine M, Kalli Kimberly R, Cunningham Julie M, Fridley Brooke L, Goode Ellen |
| ABCB1 Variation Affects Myelosuppression, Progression-free Survival and Overall Survival in Paclitaxel/Carboplatin-treated Ovarian Cancer Patients. Basic & clinical pharmacology & toxicology 2018 Mar . Björn Niclas, Jakobsen Falk Ingrid, Vergote Ignace, Gréen Henr |
- Page last reviewed:Oct 1, 2023
- Page last updated:Dec 04, 2023
- Content source: